Long Covid Syndrome

President Donald J. Trump signed an executive order withdrawing the United States from WHO, mostly due to the belief that the U.S. unfairly pays a significant proportion of WHO’s funding, especially relative to China.

On this episode, hear the 2024 updates on COVID-19, long COVID and the latest developments in research in rheumatology. Hosted by Dr. Leonard Calabrese.

Greater exposure to particulate matter in the air may be linked to longer duration of long COVID symptoms, a population-based cohort analysis published in Environmental Health Perspectives showed.

Long COVID is more prevalent among patients with all types of disabilities, and primary care providers must ensure their practices are accessible for everyone, according to an expert.

The FDA approved FluMist, a nasal spray vaccine, for self-administration in people aged 2 to 49 years, making it the first ever influenza vaccine that does not need to be administered by a health care professional, the FDA announced.

The antiviral molnupiravir modestly reduces the risk for severe symptoms of COVID-19 and may also reduce the risk for long COVID, according to a randomized controlled trial.

A 60-year-old man in Germany became the seventh person to be considered potentially cured of HIV after receiving a stem cell transplant from a person with a genetic mutation that prevents infection.

More than 70 million adults — or one in four — in the United States reported having a disability in 2022, according to a press release from the CDC.

Since the beginning of the COVID-19 pandemic, there has been a “significant decrease” in the risk for post-acute sequelae of COVID-19 among patients with rheumatic diseases, according to data published in The Journal of Rheumatology.